Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 16/20 | 1.00 |
| ▸ | BTK | Q06187 | 3/20 | 0.63 |
| ▸ | JAK3 | P52333 | 4/20 | 0.62 |
| ▸ | JAK2 | O60674 | 2/20 | 0.61 |
| ▸ | BLK | P51451 | 1/20 | 0.61 |
| ▸ | BMX | P51813 | 1/20 | 0.61 |
| ▸ | SRC | P12931 | 1/20 | 0.60 |
| ▸ | TEC | P42680 | 1/20 | 0.60 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.60 |
| ▸ | JAK1 | P23458 | 1/20 | 0.60 |
| ▸ | TYK2 | P29597 | 1/20 | 0.60 |
| ▸ | FLT3 | P36888 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10127802 | 0.93 | EGFR (0.87) | EGFRBTKJAK3JAK2BLK | |
| SCHEMBL17059604 | 0.91 | EGFR (0.85) | EGFRBTKJAK3JAK2BLK | |
| SCHEMBL17059668 | 0.91 | EGFR (0.83) | EGFRBTKJAK3 | |
| SCHEMBL17059694 | 0.90 | EGFR (1.00) | EGFRBTKJAK3JAK2BLK | |
| SCHEMBL17059644 | 0.87 | EGFR (1.00) | EGFRBTKJAK3JAK2BLK | |
| SCHEMBL10155136 | 0.87 | EGFR (0.77) | EGFRBTKJAK3JAK2BLK | |
| SCHEMBL17059682 | 0.86 | EGFR (0.76) | EGFRJAK3JAK2FLT3 | |
| SCHEMBL17059589 | 0.84 | EGFR (0.80) | EGFRBTK | |
| SCHEMBL17059681 | 0.83 | EGFR (0.72) | EGFRJAK3JAK2 | |
| SCHEMBL10127782 | 0.83 | MAP3K7 (0.75) | EGFRBTKJAK3JAK2BLK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015127873-A1 | ARYLAMINO PYRAMIDINE COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS PREPARED THEREFROM | 上海海雁医药科技有限公司 | 2015-09-03 | — | — | WO | disclosed |